LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR MOLINA INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO ...

Core Insights - Aramark has entered into a multi-year agreement with the University of Pennsylvania Health System to provide various services starting in early 2026 [1] Group 1: Agreement Details - The agreement includes the provision of patient and retail food services, environmental services, patient transportation, and an integrated call center [1] - The partnership will support operations across a nearly 4,000-bed, seven-hospital system [1] Group 2: Significance of the Partnership - This collaboration is highlighted as a significant partnership with a world-renowned health system, emphasizing its importance to the Philadelphia area [1]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you suffered losses in Nutex between August 8, 2024 and August 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leadi ...

PureHealth Holding has concluded the previously announced acquisition of its 60% interest in the Hellenic Healthcare Group (HHG) for €800m ($933m). The transaction values HHG at €1.3bn and marks a significant milestone in PureHealth's strategy to establish a globally connected healthcare platform, centred in Abu Dhabi in the United Arab Emirates. By integrating HHG's 23 diagnostic centres and 11 hospitals, PureHealth will enhance healthcare service access for more than 1.4 million patients each year. HH ...

Core Insights - Active ETFs are gaining significance among investors, with flows expected to reach another record due to increasing launches [1] - The T. Rowe Price Health Care ETF (TMED) has shown strong performance, returning 11.8% over the last three months and 10% over the last month, outperforming its category averages [1] - TMED's active management and fundamental research focus are key drivers of its solid returns, investing in a diverse range of healthcare stocks globally [1] Performance Metrics - TMED charges a fee of 44 basis points and has outperformed the ETF Database Category average of 8% and 6.3% over three and one-month periods, respectively [1] - The FactSet Segment averages were 7.6% and 5.3% for the same periods, indicating TMED's superior performance [1] - As of October 6, TMED's price was $27.97, above its 50-day simple moving average of $25.37, signaling a buy opportunity [1] Investment Strategy - TMED employs a bottom-up investment approach, holding a portfolio of 100–150 stocks across biotechnology, pharmaceuticals, products and device providers, and healthcare service companies [1] - The ETF's active strategy may benefit from falling interest rates and ongoing AI innovations, which could enhance productivity and innovation in the healthcare sector [1]

Core Insights - Three stocks are highlighted with strong momentum characteristics and a buy rank as of October 7th: eGain Corporation, StoneCo Ltd., and Alignment Healthcare, Inc. [1] Company Summaries - **eGain Corporation (EGAN)**: - Provides an AI-powered knowledge hub to enhance customer experiences - Zacks Rank 1 with a 52.2% increase in current year earnings estimate over the last 60 days - Shares increased by 51.4% in the last three months, outperforming the S&P 500's 7.8% gain - Holds a Momentum Score of A [1][2] - **StoneCo Ltd. (STNE)**: - A fintech company offering software solutions - Zacks Rank 1 with an 8.7% increase in current year earnings estimate over the last 60 days - Shares gained 9.7% in the last three months, also outperforming the S&P 500's 7.8% gain - Holds a Momentum Score of A [2] - **Alignment Healthcare, Inc. (ALHC)**: - A healthcare platform focused on seniors - Zacks Rank 1 with a 14.3% increase in current year earnings estimate over the last 60 days - Shares increased by 24.8% in the last three months, surpassing the S&P 500's 7.8% gain - Holds a Momentum Score of A [3]

Core Insights - LRT Capital Management's "LRT Global Opportunities Strategy" reported a challenging performance in September 2025, with a net return of -8.00% for the month and a year-to-date return of -0.17% [1] - The strategy employs a systematic long/short approach to generate positive returns while managing downside risks and maintaining low net exposure to equity markets [1] Company Overview: UnitedHealth Group Incorporated - UnitedHealth Group Incorporated (NYSE:UNH) is identified as a leading enterprise in the U.S. healthcare sector, operating through segments such as UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx [2][3] - The stock of UnitedHealth Group experienced a one-month return of 3.36% but has seen a significant decline of 38.16% over the past 52 weeks, closing at $358.82 per share on October 6, 2025, with a market capitalization of $326.636 billion [2] Competitive Positioning - UnitedHealth Group has established a strong competitive moat by integrating its dominant health benefits platform, UnitedHealthcare, with a rapidly growing health services business, Optum [3] - This integrated model is reshaping healthcare delivery and management, positioning UnitedHealth as a durable and elite compounding enterprise [3]

Group 1 - S&P 500 health care stocks, including Centene (CNC) and Molina Healthcare (MOH), experienced an increase after President Trump indicated a willingness to negotiate with Democrats to prevent the expiration of enhanced ACA subsidies [1] - Wells Fargo analysts now assume that the ACA subsidies will continue, contingent on Democrats agreeing to end the government shutdown [1] - Oscar Health's stock has shown improved price performance, resulting in an upgrade to its IBD Relative Strength Rating from 80 to 87 [2]

Group 1 - The article discusses an opportunity for investors in Molina Healthcare, Inc. to lead a securities fraud lawsuit with the Schall Law Firm [1] - The focus is on potential legal actions related to securities fraud, indicating a significant concern among investors regarding the company's practices [1] - The involvement of the Schall Law Firm suggests a structured approach to addressing investor grievances and pursuing legal remedies [1]

Core Viewpoint - Agilon Health, Inc. will release its financial results for Q3 2025 on November 4, 2025, after market close, and will host a conference call to discuss these results [1] Financial Results Announcement - The financial results for Q3 2025 will be announced after market close on November 4, 2025 [1] - A conference call will be held at 4:30 p.m. ET on the same day to discuss the results [1] - U.S. participants can access the call by dialing (833) 470-1428, while international participants can call +1 (404) 975-4839 [1]